Halozyme withdraws $2.1 bln buyout offer for Evotec

Halozyme Therapeutics

22/11/2024 13:44

Nov 22 (Reuters) - Halozyme Therapeutics  HALO.O  said
on Friday it had withdrawn its proposal to acquire Evotec SE
 EVTG.DE  for 2 billion euros  ($2.09 billion) after the German
drug developer was unwilling to engage in discussions.
    


($1 = 0.9587 euros)

 (Reporting by Sriparna Roy in Bengaluru; Editing by Devika
Syamnath)
 ((Sriparna.Roy@thomsonreuters.com;))